Tea and Forearm Blood Flow

August 28, 2015 updated by: Unilever R&D

Forearm Blood Flow Response to Acute Consumption of Black Tea

The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Epidemiological studies indicate that regular consumption of black tea reduces the risk of cardiovascular diseases. Tea consumption can result in improvements in endothelial function of conduit arteries as measured by flow mediated dilation.

Less is known however about its effects in other vascular beds. The study will test the hypothesis that tea affects endothelial function in the muscle microcirculation. This will be done by assessment of forearm blood flow using venous occlusion plethysmography after consumption of black tea against or placebo in a randomised, full cross-over study in 20 healthy middle-aged to elderly subjects

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and post menopausal (> 1 years) females
  • Aged ≥ 45 and ≤ 75 years
  • Body mass index (BMI) of ≥ 18.0 and ≤ 35.0 kg/m2
  • Judged to be in good health on the basis of medical history, physical examination and routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, highly sensitive C-reactive protein).
  • Normal blood coagulation as assessed by routine lab tests

Exclusion Criteria:

  • Strenuous exercise > 2 hours per week. Strenuous exercise is defined as exercise which induces sweating and causes sufficient breathlessness to limit conversation
  • Current smoker or has stopped smoking less than 6 months before start of study
  • Self reported alcohol intake of > 21 units/week)
  • Established cardiovascular disease or clinically significant arrhythmia
  • Diabetes mellitus
  • Blood pressure > 160/100 mmHg
  • Taking medication that might affect endothelial function (as judged by the PI)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Black tea
Approximately 400 mg total polyphenols in 240 ml hot water (loading dose; 2 hours before the start of measurements; t=0) and 130 mg total polyphenols in 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)
Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents
Placebo Comparator: Placebo
Caramel colour, maltodextrin and tea flavour in 240 ml hot water (2 hours before the start of measurements; t=0) and 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)
Placebo matched to tea with respect to taste and appearance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forearm blood flow response to acetylcholine
Time Frame: During acetylcholine infusion 120-140 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo
During acetylcholine infusion 120-140 min after first tea/placebo intake

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forearm blood flow response to sodium nitropusside
Time Frame: During sodium nitropusside infusion 170-190 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to sodium nitropusside when compared to placebo
During sodium nitropusside infusion 170-190 min after first tea/placebo intake
Forearm blood flow response to L-NMMA
Time Frame: During L-NMMA infusion 220-240 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to L-NG-monomethyl Arginine (L-NMMA) when compared to placebo
During L-NMMA infusion 220-240 min after first tea/placebo intake

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Sean Roerink, Dr., Radboud university medical center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

December 19, 2014

First Submitted That Met QC Criteria

December 30, 2014

First Posted (Estimate)

December 31, 2014

Study Record Updates

Last Update Posted (Estimate)

August 31, 2015

Last Update Submitted That Met QC Criteria

August 28, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • REF-BEV-1797

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Function

Clinical Trials on Tea

3
Subscribe